Your browser doesn't support javascript.
loading
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.
Solforosi, Laura; Kuipers, Harmjan; Jongeneelen, Mandy; Rosendahl Huber, Sietske K; van der Lubbe, Joan E M; Dekking, Liesbeth; Czapska-Casey, Dominika N; Izquierdo Gil, Ana; Baert, Miranda R M; Drijver, Joke; Vaneman, Joost; van Huizen, Ella; Choi, Ying; Vreugdenhil, Jessica; Kroos, Sanne; de Wilde, Adriaan H; Kourkouta, Eleni; Custers, Jerome; van der Vlugt, Remko; Veldman, Daniel; Huizingh, Jeroen; Kaszas, Krisztian; Dalebout, Tim J; Myeni, Sebenzile K; Kikkert, Marjolein; Snijder, Eric J; Barouch, Dan H; Böszörményi, Kinga P; Stammes, Marieke A; Kondova, Ivanela; Verschoor, Ernst J; Verstrepen, Babs E; Koopman, Gerrit; Mooij, Petra; Bogers, Willy M J M; van Heerden, Marjolein; Muchene, Leacky; Tolboom, Jeroen T B M; Roozendaal, Ramon; Brandenburg, Boerries; Schuitemaker, Hanneke; Wegmann, Frank; Zahn, Roland C.
Afiliação
  • Solforosi L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Kuipers H; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Jongeneelen M; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Rosendahl Huber SK; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • van der Lubbe JEM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Dekking L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Czapska-Casey DN; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Izquierdo Gil A; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Baert MRM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Drijver J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Vaneman J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • van Huizen E; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Choi Y; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Vreugdenhil J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Kroos S; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • de Wilde AH; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Kourkouta E; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Custers J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • van der Vlugt R; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Veldman D; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Huizingh J; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Kaszas K; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Dalebout TJ; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • Myeni SK; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • Kikkert M; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • Snijder EJ; Molecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Böszörményi KP; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Stammes MA; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Kondova I; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Verschoor EJ; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Verstrepen BE; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Koopman G; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Mooij P; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • Bogers WMJM; Biomedical Primate Research Centre, Rijswijk, Netherlands.
  • van Heerden M; Non-Clinical Safety Toxicology/Pathology, Janssen Research and Development, Beerse, Belgium.
  • Muchene L; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Tolboom JTBM; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Roozendaal R; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Brandenburg B; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Schuitemaker H; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Wegmann F; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
  • Zahn RC; Janssen Vaccines and Prevention B.V., Leiden, Netherlands.
J Exp Med ; 218(7)2021 07 05.
Article em En | MEDLINE | ID: mdl-33909009
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Adenoviridae / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento / Adenoviridae / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 Limite: Animals Idioma: En Revista: J Exp Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos